This week's View summarizes an article on a trial evaluating two drug-eluting stents among patients undergoing percutaneous coronary intervention and touches on key points of a review about obesity, weight loss, diabetes, and metabolic surgery.

Subscribe on iTunes | Subscribe on Google Play

Keywords: Drug-Eluting Stents, Absorbable Implants, Percutaneous Coronary Intervention, Diabetes Mellitus, Weight Loss, Body Mass Index, Obesity, Metabolic Syndrome, Thoracic Surgery, Angiography, Primary Prevention, Secondary Prevention, EaglesEyeView

< Back to Listings